The study in Nature Medicine explores the potential wider benefits and risks of diabetes drugs GLP-1 receptor agonists.

The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...

Similarly, medications like antidepressants and antihistamines aren’t harmful to your health if you take them post-expiry, although they may just be less effective. Expired vitamins also become ...

Medications for myasthenia gravis (MG) can include cholinesterase inhibitors, corticosteroids, immunosuppressants, monoclonal antibodies, and antibody fragment medications. While myasthenia gravis ...

Paralytics are used as part of general anesthesia to prevent movement during surgery. General anesthesia involves medications that put you to sleep and prevent pain, like ketamine, as well as muscle ...

A few private UK clinics may provide blood thinning medications normally given to people at high risk of a stroke. The problem is that there is little good evidence to support the microclot theory ...

Monday, Dec. 2, 2024. (AP Photo/Kathleen Batten) Patient Lory Osborn holds a Wegovy pen used in her treatment at the Medical Weight Management office at West Virginia University in Morgantown, W.Va., ...

A top doctor has revealed which common medications taken by millions could put you at risk of a heart attack. Dr Zain Hasan, an anesthetist in California, highlighted non-steroidal anti ...

Before buying any flea treatment, ask your veterinarian which medication is recommended for your cat's temperament, lifestyle, and the parasites they're most at risk for contracting where you live.

especially after medical treatment. Unfortunately, medical and surgical treatments have not ever been compared in a randomized controlled trial in patients with diverticulitis (without generalized ...

Several major pharmaceutical companies, including Pfizer, Bristol Myers Squibb and Sanofi, are set to raise prices on more than 250 branded medications in the U.S. starting Jan. 1, 2025 ...

In an e-mail to The Globe, the CLHIA said insurers “actively negotiate” for pricing rebates on medications on behalf of plan sponsors. “As is the case with the pan-Canadian Pharmaceutical ...